Prevalence of Cytoplasmic Actin Mutations in Diffuse Large B-Cell Lymphoma and Multiple Myeloma: A Functional Assessment Based on Actin Three-Dimensional Structures

Mutations in actins have been linked to several developmental diseases. Their occurrence across different cancers has, however, not been investigated. Using the cBioPortal database we show that human actins are infrequently mutated in patient samples of various cancers types. Nevertheless, ranking t...

Full description

Bibliographic Details
Main Authors: Laura Witjes, Marleen Van Troys, Bruno Verhasselt, Christophe Ampe
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/9/3093
Description
Summary:Mutations in actins have been linked to several developmental diseases. Their occurrence across different cancers has, however, not been investigated. Using the cBioPortal database we show that human actins are infrequently mutated in patient samples of various cancers types. Nevertheless, ranking these studies by mutational frequency suggest that some have a higher percentage of patients with <i>ACTB</i> and <i>ACTG1</i> mutations. Within studies on hematological cancers, mutations in <i>ACTB</i> and <i>ACTG1</i> are associated with lymphoid cancers since none have currently been reported in myeloid cancers. Within the different types of lymphoid cancers <i>ACTB</i> mutations are most frequent in diffuse large B-cell lymphoma (DLBCL) and <i>ACTG1</i> mutations in multiple myeloma. We mapped the ACTB and ACTG1 mutations found in these two cancer types on the 3D-structure of actin showing they are in regions important for actin polymer formation or binding to myosin. The potential effects of the mutations on actin properties imply that mutations in cytoplasmic actins deserve dedicated research in DLBCL and multiple myeloma.
ISSN:1661-6596
1422-0067